INTRODUCTION AND OBJECTIVES: Transient stress urinary incontinence (tSUI) can cause distress for patients undergoing prostate reducing procedures, including Holmium laser enucleation of the prostate (HoLEP). We aim to identify the incidence and predictors of tSUI following HoLEP in a single-institution, single-surgeon experience.
INTRODUCTION AND OBJECTIVES: Transient stress urinary incontinence (tSUI) can cause distress for patients undergoing prostate reducing procedures, including Holmium laser enucleation of the prostate (HoLEP). We aim to identify the incidence and predictors of tSUI following HoLEP in a single-institution, single-surgeon experience.
METHODS: We performed a retrospective review of 515 patients who underwent HoLEP at our institution by a single-surgeon (AD) between 2012 and 2017. All patients were assessed for incontinence at each visit before and after HoLEP, including an International Prostate Symptom Score (IPSS) questionnaire. Patients were stratified by preoperative transrectal ultrasound gland size (<[ 100g and >100g) and preoperative catheter dependency. Patients were seen for followup at two weeks, six weeks, and three months postoperatively. Univariate analysis was performed for baseline demographics to assess for predictors of tSUI; multivariate logistic regression analysis was run based on significant variables from univariate analysis.
RESULTS: 53/515 patients (10.3%) developed tSUI. Resolution occurred in 47/53 patients (88.6%) within the first six weeks and 6/53 (11.3%) between 6 weeks to 3 months. 38/53 (71.6%) with incontinence were catheter dependent before HoLEP. 84.8% of men with >100g prostates had incontinence resolution within six weeks. Mean prostatic volume on ultrasound was 146.9 cc in those with tSUI compared to 93.6 cc (p [ <0.0001) METHODS: From Jan. 2016 to Mar. 2018, there were 126 patients underwent HoLEP in our hospital because of LUTs caused by BPH. All the procedures were performed by a single surgeon with more than 200 HoLEP experience(Prof. Xiao). Perioperative data were recorded including PSA, IPSS score, volume measured by ultrasound, operation time and estimated blood loss. We performed MRI to every patients preoperatively, we measured the following factors: length (LP), width (WP), height (HP) and volume (PV) of the prostate,membranous urethral length (MUL), intravesical prostatic protrusion length(IPPL), urethral wall thickness (UWT), levator ani muscle (LAM) and obturator internus muscle (OIM) thickness. The membranous urethral length (MUL) was measured on coronal magnetic resonance imaging (MRI) images of each patient and was defined as the distance from the prostatic apex to the entry of the urethra into the penile bulb. IPPL was measured on MRI as the vertical distance from the tip of the protruding prostate to the base of the urinary bladder. The recovery of urinary continence was recorded postoperatively, during an 8 weeks follow up.
RESULTS: The continent rate of 2, 4, 8 weeks postoperatively were 81.0%, 89.7%, and 96.6%, respectively. Univariate obtained differences in Age, PV, MUL, and IPLL after 2 weeks of the operation. Multivariate analysis showed Age (P[0.001), MUL (P[ 0.001) and IPLL (P[ 0.012) were the independence factors for the recovery of continence of 2 weeks after surgery. Univariate obtained differences in PV, MUL, and IPLL after 4 weeks of the operation . Multivariate analysis showed Age (P[0.001) and MUL (P[ 0.013) were the independence factors for the recovery of continence of 4 weeks after surgery. No significant association except age (P[0.012) was found between MRI factors to the recovery of continence of 8 weeks after surgery.
CONCLUSIONS: MRI is a useful tool to predict UI after RP in early stage (1 month) after the procedure. The MUL and IPPL are wellidentified structures that are involved in incontinence after HoLEP.
Source of Funding: none

PD10-05 CLINICAL AND PATHOLOGIC OUTCOMES FOLLOWING HOLMIUM LASER ENUCLEATION OF THE PROSTATE IN MEN UNDERGOING ACTIVE SURVEILLANCE FOR PROSTATE CANCER
Charles Nottingham*, Tim Large, Julia Fiuk, James Lingeman, Indianapolis, IN INTRODUCTION AND OBJECTIVES: Patients with prostate cancer (PC) who wish to pursue active surveillance (AS) present a unique challenge to the urologist if these men have lower urinary tract symptoms (LUTS) or urinary retention. The objective of this study was to describe clinical and pathologic outcomes for patients on AS for PC who also underwent holmium laser enucleation of the prostate (HoLEP) for LUTS or urinary retention.
METHODS: Through an IRB-approved protocol, we prospectively collect preoperative, perioperative, and postoperative data on all patients undergoing HoLEP at our institution. We queried this database to include all men with a known diagnosis of PC who chose active surveillance as primary treatment for their malignancy. We excluded men who were planning to undergo radiation as primary cancer treatment following debulking HoLEP due to obstructive LUTS. Perioperative and postoperative patient characteristics were evaluated. RESULTS: We included 71 patients for analysis (Table 1 ). The median patient age was 74 years, and 38% of patients required an indwelling catheter or intermittent catheterization for urinary retention before surgery. Preoperatively, the majority of patients had Gleason sum 6 PC and the median PSA for the group was 9.0 ng/mL (IQR 5.9-13.6). The median weight of tissue removed was 73 grams (IQR 37-101). Most patients (63.4%) had no malignancy on HoLEP pathology, and the three patients with preoperative Gleason 7 and 8 had either Gleason 6 or no cancer on HoLEP pathology. Over a median 12-month follow-up period, all patients were free of urinary retention, and 90.1% of patients remained on AS without plans for other therapy. Median AUA symptom scores were significantly lower postoperatively compared to preoperatively (6 vs 22, respectively; p<0.01). Additionally, the PSA decreased to a median of 1.4 ng/mL (IQR 0.7-3.5).
CONCLUSIONS: In patients with LUTS or urinary retention wishing to undergo AS for PC, HoLEP will provide many men significant symptomatic improvement and relief of urinary retention while allowing them to continue this treatment option.
Source of Funding: None
PD10-06 COMPARISON OF INCIDENTAL PROSTATE CANCER DETECTION BETWEEN HOLEP AND BIPOLAR TURP
Wen Dong*, Chun Jiang, Weibin Xie, Jian Huang, Hao Huang, Xinxiang Fan, Guangzhou, China, People's Republic of INTRODUCTION AND OBJECTIVES: Holmium laser enucleation of the prostate (HoLEP) has become a popular alternative to TURP for the treatment of lower urinary tract symptoms (LUTS) secondary to benign prostate hyperplasia (BPH). Previous studies indicated that HoLEP may have a higher rate of incidental prostate cancer (iPCa) detection because of a more efficient tissue removed during surgery. However, some other studies reported it's identical for both procedures. In this study, we aim to evaluate whether the surgical procedure itself (HoLEP vs. TURP) influences iPCa detection by analysis of a large cohort of patients.
METHODS: 602 patients undergoing HoLEP (n [ 292) or TURP (n [ 312) were retrospectively analyzed for total PSA, prostate volume, PSA density, history of prostate biopsy, resected prostate weight, and histopathological features. IPSS, Qmax, PVR were also collected before and after surgery. Parameters were analyzed by Fisher's exact test and T test or Mann-Whitney U test for dichotomous and continuous variables, respectively. Univariate and multivariate logistic regression removed used to identify independent predictors of incidental PCa (iPCa).
RESULTS: Median patient age was 66 and 65 years in the HoLEP and bTURP group, respectively. Median preoperative total PSA was 3.7 ng/ml for HoLEP and 3.3 ng/ml for bTURP patients (p[0.08). Median preoperative prostate volume was 64.0 cc for HoLEP and 58.0 cc for bTURP (p[0.02). Mean percentage of tissue removed by HoLEP and bTURP was 69.5% and 51.2% (p < 0.001), respectively. IPCa was found in 12.3% of HoLEP specimens compared to 6.1% in bTURP (p [ 0.01). There were no differences for IPSS and PVR reduction, Qmax increase for each procedure. In multivariate logistic regression, we identified the choice of procedure (OR 1.46; 95% CI 1.24e1.65, p [ 0.04) and PSA density (OR 2.13; 95% CI 1.09e4.18, p [ 0.028) as independent predictors for the detection of iPCa.
CONCLUSIONS: In this study, HoLEP provides a significantly higher iPCa detection than bTURP although most of them were removed cancer.). might be a result of a more efficient tissue removal during HoLEP. HoLEP had similar effect for resolution of LUTS as bTURP.
